Expertise in
1
conditions

Markus Zeisbrich

Freiburg, BW, DE 
Expertise in
1
conditions
Freiburg, BW, DE 

Overview

Markus Zeisbrich practices practicing medicine in Freiburg, Germany.

Mr. Zeisbrich is highly rated in 1 condition, according to our data. His clinical expertise encompasses Vasculitis, Juvenile Temporal Arteritis, Temporal Arteritis, and Giant Cell Arteritis (GCA).

He is actively involved in clinical research, co-authoring 16 peer reviewed articles.

Gender

Male

Locations

Freiburg, BW, Germany
Other Locations
Heidelberg, BW, Germany

Frequently Asked Questions about Markus Zeisbrich

Is Markus Zeisbrich a top-rated expert for Vasculitis?

MediFind is an objective health platform that identifies experts based on real-world data. Markus Zeisbrich is classified as an Advanced expert for Vasculitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Markus Zeisbrich participate in research or clinical trials?

Yes. Markus Zeisbrich has published 16 articles and abstracts on conditions like Vasculitis. You can view a list of Markus Zeisbrich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zeisbrich's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile